Loxo Oncology Announces Publication of Larotrectinib Clinical Data in The New England Journal of Medicine Pharmaceutical Investing
ContraVir Pharmaceuticals Announces TXL Has Been Granted Orphan Drug Designation for the Treatment of HBV in a Pediatric Population Pharmaceutical Investing
Lexicon Pharmaceuticals Reports Fourth Quarter and Full-Year 2017 Financial Results and Provides a Business Update Biotech Investing
PRA Health Sciences Reports Fourth Quarter and Full Year 2017 Results and Provides Q1 and FY 2018 Guidance Pharmaceutical Investing
Avid Bioservices Selected as Commercial Manufacturer for Critical Enzyme Replacement Therapy by a Subsidiary of Roivant Sciences Pharmaceutical Investing
TG Therapeutics Announces Publication of Clinical Data from the Phase 1 First-in-Human Trial of Umbralisib Pharmaceutical Investing
Cyclacel Announces Notice of Grant of New European Patent Covering Sapacitabine Pharmaceutical Formulations Pharmaceutical Investing
Momenta Pharmaceuticals Reports Fourth Quarter and Year End 2017 Financial Results and Provides Corporate Update Pharmaceutical Investing
Portola Pharmaceuticals Announces Results of CHMP Oral Explanations for Andexanet Alfa and Betrixaban Pharmaceutical Investing
Ultragenyx Reports Fourth Quarter and Full Year 2017 Financial Results and Corporate Update Pharmaceutical Investing
InMed Provides Update on Pharmaceutical Development Programs - Advancing Lead Drug Candidates Towards IND and Clinical Trial
InMed Provides Update on BayMedica Operations and Strengthens Focus on Pharmaceutical Development Pipeline
